Madan Ajay

Empresas donde Madan Ajay ha operado

• Crinetics Pharmaceuticals, Inc.9 ops. · $525.6K · Mar 2, 2022

Historial de resultados de Madan Ajay

Historial insuficiente para un historial de resultados estadístico (menos de 5 compras en el mercado).

Historial de operaciones de Madan Ajay

Co-iniciados de Madan Ajay

• 5AM Co-Investors IV, L.P.Crinetics Pharmaceuticals, Inc.
• 5AM Partners IV, LLCCrinetics Pharmaceuticals, Inc.
• 5AM Ventures IV, L.P.Crinetics Pharmaceuticals, Inc.
• Bedrosian Camille LCrinetics Pharmaceuticals, Inc.
• Betz Stephen F.Crinetics Pharmaceuticals, Inc.
• Deardorf CarenCrinetics Pharmaceuticals, Inc.
• DIEKMAN JOHN DCrinetics Pharmaceuticals, Inc.
• EDELMAN JOSEPHCrinetics Pharmaceuticals, Inc.
• Freeman MasonCrinetics Pharmaceuticals, Inc.
• Fust Matthew KCrinetics Pharmaceuticals, Inc.
• Hassard JamesCrinetics Pharmaceuticals, Inc.
• Kaldor Stephen WCrinetics Pharmaceuticals, Inc.
• Kalofonos IsabelCrinetics Pharmaceuticals, Inc.
• Knight Jeff E.Crinetics Pharmaceuticals, Inc.
• Krasner Alan SethCrinetics Pharmaceuticals, Inc.
• Nichols WestonCrinetics Pharmaceuticals, Inc.
• Nielsen JackCrinetics Pharmaceuticals, Inc.
• Okey StephanieCrinetics Pharmaceuticals, Inc.
• ORBIMED ADVISORS LLCCrinetics Pharmaceuticals, Inc.
• OrbiMed Capital GP VI LLCCrinetics Pharmaceuticals, Inc.
• PERCEPTIVE ADVISORS LLCCrinetics Pharmaceuticals, Inc.
• PERCEPTIVE LIFE SCIENCES MASTER FUND LTDCrinetics Pharmaceuticals, Inc.
• Pizzuti DanaCrinetics Pharmaceuticals, Inc.
• ROCKLAGE SCOTT MCrinetics Pharmaceuticals, Inc.
• Schilke TobinCrinetics Pharmaceuticals, Inc.
• Schwab Andrew J.Crinetics Pharmaceuticals, Inc.
• Struthers Richard ScottCrinetics Pharmaceuticals, Inc.
• Versant Affiliates Fund V, L.P.Crinetics Pharmaceuticals, Inc.
• Versant Ophthalmic Affiliates I, L.P.Crinetics Pharmaceuticals, Inc.
• Versant Venture Capital V (Canada), LPCrinetics Pharmaceuticals, Inc.
• Versant Venture Capital V, L.P.Crinetics Pharmaceuticals, Inc.
• Versant Ventures V (Canada), L.P.Crinetics Pharmaceuticals, Inc.